Bone Loss Completed Phase Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00558012Zoledronic Acid for Osteoporosis in the ElderlyTreatment